Literature DB >> 21886095

Generation of transgene-free human induced pluripotent stem cells with an excisable single polycistronic vector.

Eirini P Papapetrou1, Michel Sadelain.   

Abstract

The generation of induced pluripotent stem cells (iPSCs) devoid of permanently integrated reprogramming factor genes is essential to reduce differentiation biases and artifactual phenotypes. We describe a protocol for the generation of human iPSCs using a single polycistronic lentiviral vector (pLM-fSV2A) coexpressing OCT4, SOX2, KLF4 and c-MYC; this is flanked by two loxP sites in its long terminal repeats (LTRs). Human iPSC lines are established with an efficiency of up to 1% and screened to select single or low vector copy lines. To deal with potential insertional mutagenesis, the vector integrations are then mapped to the human genome. Finally, the vector is excised by transient expression of Cre recombinase (coexpressed with mCherry) through an integrase-deficient lentiviral vector. Vector-excised iPSC lines maintain all characteristics of pluripotency. This protocol can be used to efficiently derive transgene-free iPSCs from many different starting cell types in approximately 12-14 weeks.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21886095     DOI: 10.1038/nprot.2011.374

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  40 in total

Review 1.  Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming.

Authors:  Rudolf Jaenisch; Richard Young
Journal:  Cell       Date:  2008-02-22       Impact factor: 41.582

2.  Generation of induced pluripotent stem cells from neural stem cells.

Authors:  Jeong Beom Kim; Holm Zaehres; Marcos J Araúzo-Bravo; Hans R Schöler
Journal:  Nat Protoc       Date:  2009-09-17       Impact factor: 13.491

3.  Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture.

Authors:  Louise C Laurent; Igor Ulitsky; Ileana Slavin; Ha Tran; Andrew Schork; Robert Morey; Candace Lynch; Julie V Harness; Sunray Lee; Maria J Barrero; Sherman Ku; Marina Martynova; Ruslan Semechkin; Vasiliy Galat; Joel Gottesfeld; Juan Carlos Izpisua Belmonte; Chuck Murry; Hans S Keirstead; Hyun-Sook Park; Uli Schmidt; Andrew L Laslett; Franz-Josef Muller; Caroline M Nievergelt; Ron Shamir; Jeanne F Loring
Journal:  Cell Stem Cell       Date:  2011-01-07       Impact factor: 24.633

4.  Induced pluripotent stem cells generated without viral integration.

Authors:  Matthias Stadtfeld; Masaki Nagaya; Jochen Utikal; Gordon Weir; Konrad Hochedlinger
Journal:  Science       Date:  2008-09-25       Impact factor: 47.728

5.  Generation of human-induced pluripotent stem cells.

Authors:  In-Hyun Park; Paul H Lerou; Rui Zhao; Hongguang Huo; George Q Daley
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

6.  Generation of germline-competent induced pluripotent stem cells.

Authors:  Keisuke Okita; Tomoko Ichisaka; Shinya Yamanaka
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

7.  In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state.

Authors:  Marius Wernig; Alexander Meissner; Ruth Foreman; Tobias Brambrink; Manching Ku; Konrad Hochedlinger; Bradley E Bernstein; Rudolf Jaenisch
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

8.  Genetic correction and analysis of induced pluripotent stem cells from a patient with gyrate atrophy.

Authors:  Sara E Howden; Athurva Gore; Zhe Li; Ho-Lim Fung; Benjamin S Nisler; Jeff Nie; Goukai Chen; Brian E McIntosh; Daniel R Gulbranson; Nicole R Diol; Seth M Taapken; David T Vereide; Karen Dyer Montgomery; Kun Zhang; David M Gamm; James A Thomson
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-04       Impact factor: 11.205

9.  Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds.

Authors:  Danwei Huangfu; René Maehr; Wenjun Guo; Astrid Eijkelenboom; Melinda Snitow; Alice E Chen; Douglas A Melton
Journal:  Nat Biotechnol       Date:  2008-06-22       Impact factor: 54.908

10.  piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells.

Authors:  Knut Woltjen; Iacovos P Michael; Paria Mohseni; Ridham Desai; Maria Mileikovsky; Riikka Hämäläinen; Rebecca Cowling; Wei Wang; Pentao Liu; Marina Gertsenstein; Keisuke Kaji; Hoon-Ki Sung; Andras Nagy
Journal:  Nature       Date:  2009-03-01       Impact factor: 49.962

View more
  37 in total

Review 1.  Assessing the risks of genotoxicity in the therapeutic development of induced pluripotent stem cells.

Authors:  So Gun Hong; Cynthia E Dunbar; Thomas Winkler
Journal:  Mol Ther       Date:  2012-12-04       Impact factor: 11.454

2.  Patient-derived induced pluripotent stem cells in cancer research and precision oncology.

Authors:  Eirini P Papapetrou
Journal:  Nat Med       Date:  2016-12-06       Impact factor: 53.440

3.  Generation of cell-based systems to visualize chromosome damage and translocations in living cells.

Authors:  Vassilis Roukos; Rebecca C Burgess; Tom Misteli
Journal:  Nat Protoc       Date:  2014-09-25       Impact factor: 13.491

4.  Efficient gene delivery into cell lines and stem cells using baculovirus.

Authors:  Li-Yu Sung; Chiu-Ling Chen; Shih-Yeh Lin; Kuei-Chang Li; Chia-Lin Yeh; Guan-Yu Chen; Chin-Yu Lin; Yu-Chen Hu
Journal:  Nat Protoc       Date:  2014-07-10       Impact factor: 13.491

5.  Stage-Specific Human Induced Pluripotent Stem Cells Map the Progression of Myeloid Transformation to Transplantable Leukemia.

Authors:  Andriana G Kotini; Chan-Jung Chang; Arthur Chow; Han Yuan; Tzu-Chieh Ho; Tiansu Wang; Shailee Vora; Alexander Solovyov; Chrystel Husser; Malgorzata Olszewska; Julie Teruya-Feldstein; Deepak Perumal; Virginia M Klimek; Alexandros Spyridonidis; Raajit K Rampal; Lewis Silverman; E Premkumar Reddy; Elli Papaemmanuil; Samir Parekh; Benjamin D Greenbaum; Christina S Leslie; Michael G Kharas; Eirini P Papapetrou
Journal:  Cell Stem Cell       Date:  2017-02-16       Impact factor: 24.633

Review 6.  Gene Addition Strategies for β-Thalassemia and Sickle Cell Anemia.

Authors:  Alisa C Dong; Stefano Rivella
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

7.  Characterization of a fluorescent probe for imaging nitric oxide.

Authors:  Yohannes T Ghebremariam; Ngan F Huang; Swetha Kambhampati; Katharina S Volz; Gururaj G Joshi; Eric V Anslyn; John P Cooke
Journal:  J Vasc Res       Date:  2013-12-11       Impact factor: 1.934

8.  Induced Pluripotent Stem (iPS) Cell Culture Methods and Induction of Differentiation into Endothelial Cells.

Authors:  Ishita Chatterjee; Fei Li; Erin E Kohler; Jalees Rehman; Asrar B Malik; Kishore K Wary
Journal:  Methods Mol Biol       Date:  2016

9.  The Histone Variant MacroH2A Blocks Cellular Reprogramming by Inhibiting Mesenchymal-to-Epithelial Transition.

Authors:  Maria Pliatska; Maria Kapasa; Antonis Kokkalis; Alexander Polyzos; Dimitris Thanos
Journal:  Mol Cell Biol       Date:  2018-04-30       Impact factor: 4.272

Review 10.  New frontier in regenerative medicine: site-specific gene correction in patient-specific induced pluripotent stem cells.

Authors:  Zita Garate; Brian R Davis; Oscar Quintana-Bustamante; Jose C Segovia
Journal:  Hum Gene Ther       Date:  2013-06       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.